MUSUMECI, FRANCESCA

MUSUMECI, FRANCESCA  

100006 - Dipartimento di Farmacia  

Mostra records
Risultati 1 - 20 di 79 (tempo di esecuzione: 0.026 secondi).
Titolo Data di pubblicazione Autore(i) File
3-Cyano-4,6-diphenyl-pyridine amino acid derivatives active as influenza A polymerase inhibitors 1-gen-2018 Giacchello, I.; Trist, I. M. L; Musumeci, F.; Greco, C.; D’Agostino, I.; Deodato, D.; Loregian, A.; Grossi, G.; Schenone, S.
6-Substituted pyrazolo[3,4-d]pyrimidines: new promising compounds in the fight against Neuroblastoma 1-gen-2014 Musumeci, F.; Desogus, A.; Schenone, S.; Brullo, C.; Fallacara, A. L.; Tintori, C.; Dreassi, E.; Zamperini, C.; Maga, G.; Angelucci, A.; Botta,
A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitors. 1-gen-2013 Mori, M; Tintori, C; Christopher, Rs; Radi, M; Schenone, Silvia; Musumeci, Francesca; Brullo, Chiara; Sanità, P; Delle Monache, S; Angelucci, A; Kissova, M; Crespan, E; Maga, G; Botta, M.
A combined targeted/phenotypic approach for the identification of new antiangiogenics agents active on a zebrafish model: From in silico screening to cyclodextrin formulation. 1-gen-2012 Radi, M; Evensen, L; Dreassi, E; Zamperini, C; Caporicci, M; Falchi, F; Musumeci, Francesca; Schenone, Silvia; Lorens, Jb; Botta, M.
A1 receptors ligands: past, present and future trends. 1-gen-2010 Schenone, Silvia; Brullo, Chiara; Musumeci, Francesca; Bruno, Olga; Botta, M.
An update on dual Src/Abl inhibitors 1-gen-2012 Musumeci, Francesca; Schenone, Silvia; Brullo, Chiara; Botta, M.
Analogs, formulations and derivatives of imatinib: A patent review 1-gen-2015 Musumeci, Francesca; Schenone, Silvia; Grossi, Giancarlo; Brullo, Chiara; Sanna, Monica
Anti-Survival Effect of SI306 and Its Derivatives on Human Glioblastoma Cells 1-gen-2022 Monteleone, Lorenzo; Marengo, Barbara; Musumeci, Francesca; Grossi, Giancarlo; Carbone, Anna; Valenti, Giulia E.; Domenicotti, CINZIA MARIA; Schenone, Silvia
ATP-competitive inhibitors of mTOR: an update. 1-gen-2011 Schenone, Silvia; Brullo, Chiara; Musumeci, Francesca; Radi, M; Botta, M.
Bcr-Abl tyrosine kinase inhibitors: A patent review 1-gen-2015 Desogus, Andrea; Schenone, Silvia; Brullo, Chiara; Tintori, Cristina; Musumeci, Francesca
Biologically driven synthesis of pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors: an old scaffold as a new tool for medicinal chemistry and chemical biology studies 1-gen-2014 Schenone, Silvia; Radi, M; Musumeci, Francesca; Brullo, Chiara; Botta, M.
A cascade screening approach for the identification of Bcr-Abl myristate pocket binders active against wild type and T315I mutant 1-gen-2016 Radi, Marco; Schneider, Ralf; Fallacara, Anna Lucia; Botta, Lorenzo; Crespan, Emmanuele; Tintori, Cristina; Maga, Giovanni; Kissova, Miroslava; Calgani, Alessia; Richters, André; Musumeci, Francesca; Rauh, Daniel; Schenone, Silvia
Click Chemistry, A Potent Tool in Medicinal Sciences 1-gen-2015 Musumeci, Francesca; Schenone, Silvia; Desogus, Andrea; Nieddu, E.; Deodato, D.; Botta, L.
Combining X-ray Crystallography and Molecular Modeling toward the Optimization of Pyrazolo[3,4-d]pyrimidines as Potent c-Src Inhibitors Active in Vivo against Neuroblastoma. 1-gen-2015 Tintori, C; Fallacara, Al; Radi, M; Zamperini, C; Dreassi, E; Crespan, E; Maga, G; Schenone, Silvia; Musumeci, Francesca; Brullo, Chiara; Richters, A; Gasparrini, F; Angelucci, A; Festuccia, C; Delle Monache, S; Rauh, D; Botta, M.
Coronary Artery Bypass Grafting in Patients With High Risk of Bleeding 1-gen-2022 Demal, T. J.; Fehr, S.; Mariscalco, G.; Reiter, B.; Bibiza, E.; Reichenspurner, H.; Gatti, G.; Onorati, F.; Faggian, G.; Salsano, A.; Santini, F.; Perrotti, A.; Santarpino, G.; Zanobini, M.; Saccocci, M.; Musumeci, F.; Rubino, A. S.; De Feo, M.; Bancone, C.; Nicolini, F.; Dalen, M.; Maselli, D.; Bounader, K.; Makikallio, T.; Juvonen, T.; Ruggieri, V. G.; Biancari, F.
CYP-dependent metabolism of antitumor pyrazolo[3,4-d]pyrimidine derivatives is characterized by an oxidative dechlorination reaction. 1-gen-2014 Zamperini, C; Dreassi, E; Vignaroli, G; Radi, M; Dragoni, S; Schenone, Silvia; Musumeci, Francesca; Valoti, M; Antiochia, R; Botta, M.
Design, synthesis, and biological evaluation of a new series of pyrazolo[3,4-d]pyrimidines active as SGK1 inhibitors. A lead optimization study. 1-gen-2021 Musumeci, F.; D’Antona, L.; Carbone, A.; Ortuso, F.; Alcaro, S.; Perrotti, N.; Schenone, S.
Design, synthesis, and biological evaluation of pyrazolo[3,4-d]pyrimidines active in vivo on the Bcr-Abl T315I mutant. 1-gen-2013 Radi, M; Tintori, C; Musumeci, Francesca; Brullo, Chiara; Zamperini, C; Dreassi, E; Fallacara, Al; Vignaroli, G; Crespan, E; Zanoli, S; Laurenzana, I; Filippi, I; Maga, G; Schenone, Silvia; Angelucci, A; Botta, M.
Design, synthesis, biological activity, and ADME properties of pyrazolo[3,4-d]pyrimidines active in hypoxic human leukemia cells: a lead optimization study. 1-gen-2011 Radi, M; Dreassi, E; Brullo, Chiara; Crespan, E; Tintori, C; Bernardo, V; Valoti, M; Zamperini, C; Daigl, H; Musumeci, Francesca; Carraro, F; Naldini, A; Filippi, I; Maga, G; Schenone, Silvia; Botta, M.
Development of a new potential theranostic prodrug for targeting glioblastoma multiforme 1-gen-2022 Carbone, A.; D’Agostino, I.; Cianciusi, A.; Musumeci, F.; Salis, A.; D’Antona, L.; Petroni, D.; Dreassi, E.; Menichetti, L.; Schenone, S.